Case Report: Exceptional response to perioperative pembrolizumab in UV-signature melanoma of unknown primary presenting as an isolated pulmonary metastasis

Austin Drysch, Genti Gjyzeli, Paul Buttars, Sunandana Chandra, Kalvin Lung

Open source

DOI
10.3389/fonc.2026.1860040
Published
9
Container
Frontiers in Oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1860040,
  title = {Case Report: Exceptional response to perioperative pembrolizumab in UV-signature melanoma of unknown primary presenting as an isolated pulmonary metastasis},
  author = {Austin Drysch and Genti Gjyzeli and Paul Buttars and Sunandana Chandra and Kalvin Lung},
  year = {2026},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2026.1860040},
  url = {https://doi.org/10.3389/fonc.2026.1860040}
}

RIS

TY  - JOUR
TI  - Case Report: Exceptional response to perioperative pembrolizumab in UV-signature melanoma of unknown primary presenting as an isolated pulmonary metastasis
AU  - Austin Drysch
AU  - Genti Gjyzeli
AU  - Paul Buttars
AU  - Sunandana Chandra
AU  - Kalvin Lung
PY  - 2026
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1860040
UR  - https://doi.org/10.3389/fonc.2026.1860040
ER  - 

APA

Drysch, A., Gjyzeli, G., Buttars, P., Chandra, S., & Lung, K. (2026). Case Report: Exceptional response to perioperative pembrolizumab in UV-signature melanoma of unknown primary presenting as an isolated pulmonary metastasis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1860040

Source records